Paclitaxel/carboplatin administration along with antiangiogenic therapy in non-small-cell lung and breast carcinoma models

Cancer Chemotherapy and Pharmacology
Roy S HerbstB A Teicher

Abstract

With the introduction of new drugs, the efficacy of chemotherapy in non-small-cell lung cancer has been improving. The combination of paclitaxel and carboplatin has shown activity in this disease but is far from curative. The antiangiogenic agent regimen of TNP-470/minocycline was added to treatment with paclitaxel and carboplatin alone and in combination in animals bearing the Lewis lung carcinoma. Administration of the antiangiogenic regimen prior to, during and after the cytotoxic therapy increased the tumor growth delay 1.6-fold and decreased the number of lung metastases to 20% of the number observed in the control animals. [14C]Paclitaxel, platinum from carboplatin and [14C]albumin levels were determined over a 24-h time course in tumors and normal tissues of animals bearing the Lewis lung carcinoma and pretreated with TNP-470/minocycline or not pretreated. There were higher levels of [14C]paclitaxel, platinum from carboplatin and [14C]albumin in the tumors and some normal tissues of the animals that had received TNP-470/minocycline compared with those that had not received TNP-470/minocycline, especially at the earlier time points. Administration of TNP-470/minocycline to animals bearing the EMT-6 mammary carcinoma incre...Continue Reading

Citations

Jun 5, 2002·Current Oncology Reports·Edward S Kim, Roy S Herbst
Jul 18, 2003·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Frances A Shepherd, Srikala S Sridhar
Nov 13, 2003·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Srikala S Sridhar, Frances A Shepherd
Nov 25, 2000·Journal of Pharmacological and Toxicological Methods·S FarinelleR Kiss
Jul 16, 2003·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Henk J BroxtermanKlaas Hoekman
May 19, 2012·Expert Review of Anticancer Therapy·Maria Ignez BraghiroliPaulo M Hoff
May 19, 2009·Expert Review of Anticancer Therapy·Jens Soltau, Joachim Drevs
Jul 2, 2005·Expert Opinion on Emerging Drugs·K J O'Byrne, W P Steward
Nov 4, 2000·Expert Opinion on Investigational Drugs·E A Kruger, W D Figg
Aug 2, 2007·Expert Opinion on Biological Therapy·Francesco Grossi, Marianna Aita
May 9, 2012·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Esther A KleibeukerVictor L Thijssen
Aug 10, 2000·Neoplasia : an International Journal for Oncology Research·R J GilliesN Raghunand
Jul 9, 2008·Critical Reviews in Oncology/hematology·Marianna AitaFrancesco Grossi
Oct 12, 2004·Hematology/oncology Clinics of North America·Fiona H Blackhall, Frances A Shepherd
Jun 14, 2005·Expert Opinion on Therapeutic Targets·Nicholas W ChoongRavi Salgia
Jun 13, 2015·BioMed Research International·Amelia KellarDon Morris
May 12, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Roy S HerbstAlan Sandler
Jun 1, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David H JohnsonFairooz Kabbinavar
Feb 19, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Giampietro GaspariniBeverly A Teicher
Nov 15, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Roy S HerbstWaun Ki Hong
Dec 23, 2008·Toxicologic Pathology·Beverly A Teicher
Jan 8, 2005·World Journal of Gastroenterology : WJG·Lin JiaWen-Ge Huang
Feb 3, 2005·International Journal of Cancer. Journal International Du Cancer·Ruud P M DingsRobert J Griffin
Mar 20, 1999·Current Opinion in Pediatrics·J B Rubin, M W Kieran
Feb 3, 2018·Expert Opinion on Drug Discovery·Aditi P SinghHaiying Cheng
May 18, 2000·Cancer Treatment Reviews·M M EatockS B Kaye

❮ Previous
Next ❯

Related Concepts

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

© 2022 Meta ULC. All rights reserved